Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2003

View Archived Issues

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Biomira

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Cel-Sci

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: BioSante

Pivotal trial commences for Acapodene in advanced prostate cancer

Series B financing supports clinical development programs at Saegis

New bradykinin B2 modulators and their use reported by Ortho-McNeil

Roche claims new c-Met kinase inhibitors and their use in cancer therapy

Novel glucocorticoid receptor modulators covered by Merck patent

Celltech researchers describe new IMPDH inhibitors in a recent patent

Astex prepares and tests new series of p38 MAP kinase inhibitors

Novel antiangiogenic agents revealed in recent Abbott patent

Indian investigators report COX inhibitors for pain, fever and inflammation

Antibacterial steroids designed by Leo Pharma scientists

Novel GH secretagogues, their preparation and use, claimed by Lilly

IND filed for phase I/II trial of AME-527 for rheumatoid arthritis

Advair Diskus receives FDA approval

Genome Therapeutics and GeneSoft to merge

GPI-1485 enters phase II trial for postprostatectomy erectile dysfunction

Icatibant awarded orphan drug status for angioedema

Approvable letter for Topamax in the prophylaxis of migraine

Positive preliminary results for safinamide in phase II epilepsy study

Vfend approved for esophageal candidiasis

New analysis of data from TNF-alpha AutoVac trial shows antibody levels

NDA submitted for ezetimibe/simvastatin

L-type calcium channel blocker with strong visceral antinociceptive effects

Improvement in cognitive performance seen in sleep-deprived primates treated with Ampakine compound

Potent, selective, nonpeptide MCH1 receptor antagonist with anorexic activity

Transgene discusses findings on new agents for gene therapy at European meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...